Darolutamide (BAY1841788, Nubeqa) clinical trials

A Study to Compare Darolutamide Given With Androgen Deprivation Therapy (ADT) and Placebo Given With ADT in Men With Hormone Sensitive Prostate Cancer and Raise of Prostate Specific Antigen (PSA) Levels After Local Therapies

This study looks at a new way to treat prostate cancer that has come back. It combines a drug called darolutamide with standard hormone therapy, aiming to stop the cancer from spreading. Researchers want to see if this combination helps men live longer without their cancer getting worse.